Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series
- PMID: 22209206
- DOI: 10.1016/j.bmcl.2011.12.002
Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series
Abstract
Inhibition of stearoyl-CoA desaturase (SCD) activity represents a potential novel mechanism for the treatment of metabolic disorders including obesity and type II diabetes. To circumvent skin and eye adverse events observed in rodents with systemically-distributed SCD inhibitors, our research efforts have been focused on the search for new and structurally diverse liver-targeted SCD inhibitors. This work has led to the discovery of novel, potent and structurally diverse liver-targeted bispyrrolidine SCD inhibitors. These compounds possess suitable cellular activity and pharmacokinetic properties to inhibit liver SCD activity in a mouse pharmacodynamic model.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series.Bioorg Med Chem Lett. 2012 Jan 1;22(1):623-7. doi: 10.1016/j.bmcl.2011.10.070. Epub 2011 Oct 28. Bioorg Med Chem Lett. 2012. PMID: 22101133
-
Conversion of systemically-distributed triazole-based stearoyl-CoA desaturase (SCD) uHTS hits into liver-targeted SCD inhibitors.Bioorg Med Chem Lett. 2011 Nov 1;21(21):6505-9. doi: 10.1016/j.bmcl.2011.08.073. Epub 2011 Aug 25. Bioorg Med Chem Lett. 2011. PMID: 21924609
-
2-Aryl benzimidazoles: human SCD1-specific stearoyl coenzyme-A desaturase inhibitors.Bioorg Med Chem Lett. 2010 Nov 15;20(22):6366-9. doi: 10.1016/j.bmcl.2010.09.094. Epub 2010 Sep 19. Bioorg Med Chem Lett. 2010. PMID: 20933412
-
An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 - 2013).Expert Opin Ther Pat. 2014 Feb;24(2):155-75. doi: 10.1517/13543776.2014.851669. Epub 2013 Nov 20. Expert Opin Ther Pat. 2014. PMID: 24251719 Review.
-
Stearoyl-CoA desaturase as a new drug target for obesity treatment.Obes Rev. 2005 May;6(2):169-74. doi: 10.1111/j.1467-789X.2005.00177.x. Obes Rev. 2005. PMID: 15836467 Review.
Cited by
-
Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1.Bioorg Med Chem Lett. 2013 Sep 15;23(18):5091-6. doi: 10.1016/j.bmcl.2013.07.029. Epub 2013 Jul 23. Bioorg Med Chem Lett. 2013. PMID: 23932792 Free PMC article.
-
An insight into advances and challenges in the development of potential stearoyl Co-A desaturase 1 inhibitors.RSC Adv. 2024 Sep 24;14(41):30487-30517. doi: 10.1039/d4ra06237j. eCollection 2024 Sep 18. RSC Adv. 2024. PMID: 39318456 Free PMC article. Review.
-
Lowering Lipophilicity by Adding Carbon: AzaSpiroHeptanes, a logD Lowering Twist.ACS Med Chem Lett. 2019 Jul 18;10(8):1198-1204. doi: 10.1021/acsmedchemlett.9b00248. eCollection 2019 Aug 8. ACS Med Chem Lett. 2019. PMID: 31417667 Free PMC article.
-
Applications of palladium-catalyzed C-N cross-coupling reactions in pharmaceutical compounds.RSC Adv. 2023 Jun 20;13(27):18715-18733. doi: 10.1039/d2ra07412e. eCollection 2023 Jun 15. RSC Adv. 2023. PMID: 37346956 Free PMC article. Review.
-
Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels.Bioorg Med Chem Lett. 2022 Nov 15;76:129013. doi: 10.1016/j.bmcl.2022.129013. Epub 2022 Sep 29. Bioorg Med Chem Lett. 2022. PMID: 36184030 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information